Microthrombosis after aneurysmal subarachnoid hemorrhage (aSAH) is considered to
initiate neuroinflammation, vessel remodeling, and blood-brain barrier leakage. We aimed to …

Purpose Aneurysmal subarachnoid hemorrhage (SAH) is associated with high morbidity
and mortality, but currently no single clinical method or ancillary test can reliably predict …

Opinion statement New neuroprotective treatments aimed at preventing or minimizing
“delayed brain injury” are attractive areas of investigation and hold the potential to have …

Background: Delayed cerebral ischemia (DCI) is a common and serious complication of
aneurysmal subarachnoid hemorrhage (aSAH). Though many clinical trials have looked at …

Background and Purpose—The goal of this prospective study was to clarify the potential role
of an inducible heme-metabolizing enzyme, heme oxygenase (HO)-1, and an inducible iron …

Delayed cerebral ischemia is a major predictor of poor outcomes in patients who suffer
subarachnoid hemorrhage. Treatment options are limited and often ineffective despite many …

Background Early brain injury (EBI) following aneurysmal subarachnoid hemorrhage (SAH)
is an important predictor of poor functional outcome, yet the underlying mechanism is not …

Aneurysmal subarachnoid hemorrhage (SAH) is associated with numerous “delayed
neurological deficits”(DNDs) that have been attributed to multiple pathophysiological …

Background and Purpose—Anemia after aneurysmal subarachnoid hemorrhage is common
and potentially modifiable. Here, we first evaluate the effect of anemia on neurological …

Anemia is very common in aneurysmal subarachnoid hemorrhage (aSAH), with
approximately half of the aSAH patient population developing moderate anemia during their …